Japan was isolated from the world until almost the end of the 19th century, and in that period, called Edo or Tokugawa, traditional Japanese medicine -the Kampo-, based on plants, flourished. This type of alternative therapy, of Chinese origin, focuses on the patient’s condition and not on his or her disease, and its remedies for headache, atopic skin or any inflammatory disease are covered by the Japanese health system.
Takeda, which is part of the Tressis Cartera Eco30 fund, advised by this newspaper, has four main shareholders: The Master Trust Bank of Japan, Bank of New York Mellon, Japan Trustee Services Bank and JP Morgan Chase.
The Japanese firm plans to launch 12 new treatments on the market in 2024, and just a month ago announced revenue expectations for 2030 of over 5 trillion yen (about 38.2 billion euros at current exchange rates).
To view the J.P. Morgan Healthcare Congressional presentation slides and a link to the audio webcast, please visit Takeda’s website: https://www.takeda.com/investors/ir-events/.
Takeda’s financial statements are prepared in accordance with International Financial Reporting Standards (“IFRS”). Conversions of figures from JPY to USD have been made for the convenience of the reader for reference purposes and have been calculated at a JPY/USD rate of 110.6.
Further information on certain of Takeda’s non-IFRS measures is published on Takeda’s investor relations website at https://www.takeda.com/investors/financial-results/.
1 The benchmark for incremental revenue growth is fiscal 2020 reported revenue, adjusted for divested assets. All revenue figures are adjusted for regulatory and development risk. Actual future net sales achieved by our marketed products and product portfolios in development will differ, perhaps even substantially, as there is a range of possible outcomes from clinical development, driven by a number of variables, in particular, product safety, efficacy and labeling. In addition, if a product is approved, the effect of commercial factors, in particular, patient population, competitive environment, price and reimbursement, is also uncertain.
When Takeda was considering the expansion of its production center, it was very clear that the warehouse had to be automatic, as this would provide perfect control of the stored goods, as well as being able to reach the maximum height allowed, given that the space available for the construction of the warehouse was limited.
The installation consists of two aisles through which two automatic stacker cranes move independently, handling the pallets stored in double-deep racks (two pallets at the bottom of each level). Thanks to an optimal use of space, Takeda’s warehouse has a storage capacity of more than 6,500 pallets in an area of only 950 m2.
The warehouse has been equipped with an air temperature and humidity control system (HVAC – Heating Ventilation Air Conditioning) that maintains the temperature between 16 and 24 °C and prevents the humidity level from exceeding 70%, which could affect the stored goods. An innovative fire-fighting system (inerting) has also been used to reduce the amount of oxygen in the atmosphere to 15% to prevent the formation of flames.
Chobei takeda i
The injury analysis for the period from the IP to 2009 (see recitals 90 to 111) shows that a considerable deterioration of the economic situation of the Community industry is already taking place and is expected to continue and may even worsen in the near future.
Article 1(2), second indent, Article 1(3), Annex II listing the quotas applicable to certain products originating in China, Annex III listing the Chinese products subject to surveillance measures and the references to Annex III in Article 1(4) and Article 4(3)(a) of Council Regulation (EC) No 519/94. eur-lex.europa.eu